Feb 28 |
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
|
Feb 27 |
Kiniksa Pharmaceuticals Q4 2023 Earnings Preview
|
Feb 21 |
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
|
Feb 12 |
Wall Street Analysts Predict a 38.07% Upside in Kiniksa Pharmaceuticals, Ltd. (KNSA): Here's What You Should Know
|
Feb 12 |
Kiniksa Pharmaceuticals, Ltd. (KNSA) is on the Move, Here's Why the Trend Could be Sustainable
|
Jan 23 |
How Much Upside is Left in Kiniksa Pharmaceuticals, Ltd. (KNSA)? Wall Street Analysts Think 43.93%
|
Jan 23 |
Recent Price Trend in Kiniksa Pharmaceuticals, Ltd. (KNSA) is Your Friend, Here's Why
|
Jan 15 |
Investors in Kiniksa Pharmaceuticals (NASDAQ:KNSA) have seen returns of 30% over the past year
|
Jan 9 |
Is Kiniksa Pharmaceuticals (KNSA) Stock a Solid Choice Right Now?
|
Jan 5 |
Kiniksa Pharmaceuticals: Early 2024 Corporate Update A Mixed Bag
|